Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sun Pharma Seeks Recall Of Unapproved Phenobarbital Following Approval Of Its Product
Aug 21 2023
•
By
Brenda Sandburg
FDA is asked to order recall of unapproved phenobarbital sodium products • Source: Shutterstock
More from US FDA
More from Agency Leadership